Caricamento...
Using genetic drug-target networks to develop new drug hypotheses for major depressive disorder
The major depressive disorder (MDD) working group of the Psychiatric Genomics Consortium (PGC) has published a genome-wide association study (GWAS) for MDD in 130,664 cases, identifying 44 risk variants. We used these results to investigate potential drug targets and repurposing opportunities. We bu...
Salvato in:
| Pubblicato in: | Transl Psychiatry |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Nature Publishing Group UK
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6420656/ https://ncbi.nlm.nih.gov/pubmed/30877270 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41398-019-0451-4 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|